The following message was updated on 9/8/2022 4:23:05 PM.
|Msg 850 of 869 at 9/4/2022 7:31:42 AM by
Regulus Therapeutics to Participate in Upcoming Investor Conferences - Edit
Edit: The WF event is just one on one, so no way for us to know if there is anything going on.
Not clear how we might be able to view the Well Fargo event, but the HCW should be available. I tried to register for the Wells Fargo event, but it sounded like you need to be a client of WF.
SAN DIEGO, Sept. 2, 2022 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that the Company will participate in two upcoming investor conferences.
Details are as follows:
- Wells Fargo Healthcare Conference taking place September 7-9, 2022, in Boston, MA
- H.C. Wainwright 24th Annual Global Investment Conference taking place September 12-14, 2022, in New York, NY
- Jay Hagan, President and Chief Executive Officer of Regulus, will give a live presentation on Monday, September 12, 2022, at 2:30 p.m. ET
A replay of the live presentation will be available under "Events and Presentations" through the investor relations section of the Company's website at www.regulusrx.com and archived for 30 days following the presentation date.